Latest Stories
AVO Q4 Deep Dive: Volume Growth and Calavo Acquisition Shape Mission Produce’s Outlook
Avocado company Mission Produce (NASDAQ:AVO) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 16.6% year on year to $278.6 million. Its non-GAAP profit of $0.10 per share was 36.4% above analysts’ consensus estimates.
DG Q4 Deep Dive: Value Initiatives and Efficiency Programs Shape 2026 Outlook
Discount retailer Dollar General (NYSE:DG) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 5.9% year on year to $10.91 billion. Its GAAP profit of $1.93 per share was 17.6% above analysts’ consensus estimates.
ULTA Q4 Deep Dive: Margin Contraction and Strategic Investments Temper Positive Sales Growth
Beauty, cosmetics, and personal care retailer Ulta Beauty (NASDAQ:ULTA) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 11.8% year on year to $3.90 billion. Its GAAP profit of $8.01 per share was in line with analysts’ consensus estimates.
SNBR Q4 Deep Dive: New Product Launches and Cost Cuts Shape Turnaround Effort
Bedding manufacturer and retailer Sleep Number (NASDAQ:SNBR) beat Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 7.8% year on year to $347.4 million. Its non-GAAP loss of $1.95 per share was significantly below analysts’ consensus estimates.
DKS Q4 Deep Dive: Foot Locker Integration and Omnichannel Expansion Define Outlook
Sporting goods retailer Dick’s Sporting Goods (NYSE:DKS) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 59.9% year on year to $6.23 billion. The company’s full-year revenue guidance of $22.25 billion at the midpoint came in 2.2% above analysts’ estimates. Its non-GAAP profit of $3.45 per share was 17.4% above analysts’ consensus estimates.
1 Cash-Burning Stock with Impressive Fundamentals and 2 We Question
Companies that burn cash at a rapid pace can run into serious trouble if they fail to secure funding. Without a clear path to profitability, these businesses risk dilution, mounting debt, or even bankruptcy.
3 of Wall Street’s Favorite Stocks We Approach with Caution
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
1 Value Stock to Own for Decades and 2 We Ignore
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
3 Healthcare Stocks We’re Skeptical Of
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 3.8%, nearly mirrorring the S&P 500.
3 Profitable Stocks We Steer Clear Of
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.